Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1991-03-25
1992-11-10
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514459, 514466, 514519, 514521, 514528, 514529, 514533, 514548, H61K 31225, H61K 3135, H61K 3136, H61K 31275, H61K 31215, H61K 31235
Patent
active
051623722
ABSTRACT:
Compounds of formula (II) ##STR1## wherein R.sub.1 and R.sub.2 are each separately selected from hydrogen, alkyl, alkenyl and alkynyl groups having up to a maximum of four carbon atoms and being unsubstituted, and alkyl, alkenyl and alkynyl groups having up to a maximum of three carbon atoms and being substituted by one, or in the case of fluoro by one or more, substituents but with the proviso that when R.sub.1 is hydrogen then R.sub.2 is hydrogen or methyl, or R.sub.1 and R.sub.2 together constitute an ethylene bridging group, and R.sub.3 is a group which under physiological conditions undergoes elimination with the formation of a 3,5-dioxopiperazinyl ring, with the further proviso that the compound is in the meso or erythro configuration when each of R.sub.1 and R.sub.2 is the same or different unsubstituted or substituted alkyl, alkenyl or alkynyl group, and salts thereof with a physiologically acceptable inorganic or organic acid, are of value as prodrugs, particularly in the therapy of cancers sensitive to the compounds of formula (II) and psoriasis.
REFERENCES:
patent: 3164580 (1965-02-01), Matson
patent: 3351658 (1967-02-01), Bersworth
patent: 3497535 (1970-03-01), Lennon
patent: 3941790 (1976-11-01), Creighton
patent: 4275063 (1981-05-01), Creighton
patent: 4432907 (1984-07-01), Wieder
Creighton, Chem. Abstract, 93:197550 d(1980).
Sinkulaa et al., Jour. of Pharmaceutical Sc. 1975 vol. 64, pp. 181-210.
Zhang et al., Acta Pharmaceutica Sinica, 1980 vol. 15, pp. 557-583.
Ren et al., Abs. of Papers of the Ame. Chem. Soc. Aug. 1981, vol. 182, No. 18.
Houghton et al., Jour. of the Chem. Soc. Perkins Transactions I, 1982, pp. 2693-2696.
Creighton et al., Scientific Rep. of the Imperial Cancer Res. Fund for 1983-1984, Apr. 2, 1985.
Creighton et al., Abstract of the 14th International Congress of Chemotherapy, Kyoto, Jpan (Jun. 23 to 28, 1985) No. S-10-1.
Cai et al., Poster Session of the 14th International Congress of Chemotherapy, Kyoto, Japan (Jun. 23-28, 1985).
Creighton et al., "Recent Advances in Chemotherapy" (Proc. of the 14th International Congress of Chem), pp. 471-482 (1985).
Herman, E. H. et al., "Comparison of the Protective Effect of ICRF-187 . . . " Research Comm. in Chemical Pathology & Pharmacology, vol. 48, No. 1, Apr., 1985 pp. 39-55.
May, P. M. et al., "Metal Binding by Pharmaceuticals . . . " Agents and Actions, vol. 15, 3/4 (1984) pp. 448-453.
Herman et al., "Biological Properties of ICRF-159 . . . " Advances in Pharmacology, vol. 19, pp. 249-291 (1982).
Herman et al., "Comparison of the Effectiveness . . . " Cancer Research 45, 276-281, Jan., 1985.
Von Hoff et al., "Phase 1 Study of ICRF-187 . . . " Cancer Treatment Reports vol. 65, No. 3-4 Mar.-Apr., 1981.
Creighton Andrew M.
Jeffery William A.
Goldberg Jerome D.
National Research Development Corporation
LandOfFree
Pharmaceutical compositions for treating certain cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for treating certain cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for treating certain cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2293271